Navigation Links
Arthralgia in Medical News

Study Evaluating Efficacy and Safety of Two Low-dose Regimens of PREMARIN Vaginal Cream for the Treatment of Moderate to Severe Vaginal Atrophy Now Published

... or endometrial carcinoma in these women in either regimen. In this study, the most common treatment emergent AE's were headache, infection, arthralgia and vaginitis. About PREMARIN Vaginal Cream PREMARIN Vaginal Cream is used to treat menopausal changes in and around the ...

Cimzia(R) (certolizumab pegol) Now Available for Self-Administration in Adult Patients With Moderate to Severe Crohn's Disease

... frequently than with placebo (n=614) were upper respiratory infection (20% CIMZIA, 13% placebo), urinary tract infection (7% CIMZIA, 6% placebo), and arthralgia (6% CIMZIA, 4% placebo). The proportion of patients who discontinued treatment due to adverse reactions in the controlled clinical studies was 8% for ...

UCB's CIMZIA(R) (certolizumab pegol) Approved by the U.S. FDA for Adult Patients Suffering From Moderate to Severe Rheumatoid Arthritis

... frequently than with placebo (n=614) were upper respiratory infection (20% CIMZIA, 13% placebo), urinary tract infection (7% CIMZIA, 6% placebo), and arthralgia (6% CIMZIA, 4% placebo). The proportion of patients who discontinued treatment due to adverse reactions in the controlled clinical studies was 8% for ...

Arena Pharmaceuticals Announces Positive Lorcaserin Pivotal Phase 3 Obesity Trial Results: Meets All Primary Efficacy and Safety Endpoints

... respectively, were as follows: upper respiratory tract infection (14.5% vs. 16.1%), nasopharyngitis (16.4% vs. 12.6%), sinusitis (8.6% vs. 6.9%), arthralgia (6.6% vs. 6.2%) and influenza (6.6% vs. 6.0%). In patients crossing over from lorcaserin to placebo after Year 1, the rates of these Year 2 adverse ...

Data on VELCADE(R) (Bortezomib) for Injection Based Therapies to be Presented at the International Myeloma Workshop

... anemia (29%), edema (23%), headache, paresthesia and dysesthesia and headache (each 22%), dyspnea (21%), cough and insomnia (each 20%), rash (18%), arthralgia (17%), neutropenia and dizziness (excluding vertigo) (each 17%), pain in limb and abdominal pain (each 15%), bone pain (14%), back pain and ...

PEGASYS(R) Proven Effective as Hepatitis C Treatment for Latino Patients, According to Article in The New England Journal of Medicine

... percent), neutropenia (27 percent), nausea/vomiting (25 percent), rigors (25 percent), anorexia (24 percent), injection site reaction (23 percent), arthralgia (22 percent), depression (20 percent), pruritus (19 percent) and dermatitis (16 percent). Serious adverse events in hepatitis C trials ...

Combination of TYKERB(R) (lapatinib) Plus Letrozole Demonstrated Significant Improvement in Delaying Disease Progression for HER2+/ErbB2+ Post-Menopausal Metastatic Breast Cancer

... letrozole treatment alone (11.9 months versus 10.8 months, HR=0.86, p=0.026). The most common adverse events were diarrhea, rash, nausea, arthralgia and fatigue. Grade 3/4 adverse events that occurred in more than two percent of patients in either the combination arm or monotherapy arm included ...

FDA Approves VELCADE(R) (Bortezomib) for Injection for Patients with Previously Untreated Multiple Myeloma

... anemia (29%), edema (23%), headache, paresthesia and dysesthesia and headache (each 22%), dyspnea (21%), cough and insomnia (each 20%), rash (18%), arthralgia (17%), neutropenia and dizziness (excluding vertigo) (each 17%), pain in limb and abdominal pain (each 15%), bone pain (14%), back pain and ...

Newly-Approved Cimzia(R) Provides Rapid, Sustained Response in Crohn's Patients

... than with placebo (n=614) were upper respiratory infection (20% Cimzia(R), 13% placebo), urinary tract infection (7% Cimzia(R), 6% placebo), and arthralgia (6% Cimzia(R), 4% placebo). The proportion of patients who discontinued treatment due to adverse reactions in the controlled clinical studies was 8% ...

Ferring Pharmaceuticals' EUFLEXXA(R) to Serve as a Sponsor for the Babolat World Tennis Classic

... In a randomized, double-blind, multicenter clinical trial, the only adverse events reported with EUFLEXXA(R) at an incidence of 5% or greater were arthralgia (joint pain) (8.75%) and back pain (5%). Temporary knee pain and swelling may occur after injection with EUFLEXXA(R). The safety and effectiveness of ...
Arthralgia in Medical Technology

New Phase III Data Presented for Once Monthly Dosing Regimen of Risedronate to Treat Postmenopausal Osteoporosis

... 5 mg 29.9%), back pain (23.6% vs 26.1%), and arthralgia (21.1% vs 23.7%). In a clinical trial comparing ... (Actonel 35 mg 20.6% vs Actonel 5 mg 19.0%), arthralgia (14.2% vs 11.5%) and constipation (12.2% vs ... adverse events regardless of causality were arthralgia (Actonel 75 mg 10.4% vs Actonel 5 mg 9.5%), ...

Continued Overall Survival Advantage Reported From Pivotal Trial of VELCADE(R) (Bortezomib) for Injection Based Therapy in Patients With Previously Untreated Multiple Myeloma

... (each 22%), dyspnea (21%), cough and insomnia (each 20%), rash (18%), arthralgia (17%), neutropenia and dizziness (excluding vertigo) (each 17%), pain in ... (11% vs 7%), nasopharyngitis (11% vs 8%), bone pain (11% vs 10%), arthralgia (11% vs 15%) and pruritus (10% vs 5%). About Millennium ...

Prolonged Progression-Free Survival Demonstrated by VELCADE(R) (Bortezomib) for Injection Based Induction Regimens in Transplant-Eligible Previously Untreated Multiple Myeloma Patients

... (each 22%), dyspnea (21%), cough and insomnia (each 20%), rash (18%), arthralgia (17%), neutropenia and dizziness (excluding vertigo) (each 17%), pain in ... (11% vs 7%), nasopharyngitis (11% vs 8%), bone pain (11% vs 10%), arthralgia (11% vs 15%) and pruritus (10% vs 5%). About Millennium ...

Novel VELCADE(R) (Bortezomib) for Injection Based Four-Drug Combination Was Well Tolerated In Previously Untreated Multiple Myeloma Patients

... (each 22%), dyspnea (21%), cough and insomnia (each 20%), rash (18%), arthralgia (17%), neutropenia and dizziness (excluding vertigo) (each 17%), pain in ... (11% vs 7%), nasopharyngitis (11% vs 8%), bone pain (11% vs 10%), arthralgia (11% vs 15%) and pruritus (10% vs 5%). About Millennium ...

Study Shows EUFLEXXA(R) Patients Report Significant Improvements in Osteoarthritis of the Knee Pain over a Six Month Period

... events occurred in IA-hyaluronan (n=10) and IA-saline (n=9) groups. arthralgia occurred in IA-hyaluronan (n=27) and IA-saline (n=35) groups. About ... events reported with EUFLEXXA(R) at an incidence of 5% or greater were arthralgia (joint pain) (8.75%) and back pain (5%). Temporary knee pain and swelling ...

New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients

... (11% vs 7%), nasopharyngitis (11% vs 8%), bone pain (11% vs 10%), arthralgia (11% vs 15%) and pruritus (10% vs 5%). Important Safety Information In ... (each 22%), dyspnea (21%), cough and insomnia (each 20%), rash (18%), arthralgia (17%), neutropenia and dizziness (excluding vertigo) (each 17%), pain in ...

5-Year Study Published in Diabetologia Demonstrated Long-Term Safety of Lantus(R) Compared to NPH

... the study were: upper respiratory tract infection (glargine 149 [29%], NPH 169 [33.6%]), peripheral edema (glargine 103 [20%], NPH 114 [22.7%]), and arthralgia (glargine 73 [14.2%], NPH 81 [16.1%]). About the study This long-term study was designed to further characterize the retinal safety ...

Amicus Therapeutics Commences Phase 3 Trial Evaluating Amigal(TM) for the Treatment of Fabry Disease

... that treatment with Amigal was generally well-tolerated, with no drug-related serious adverse events. The most common adverse events were headache, arthralgia and diarrhea. In subjects identified as responders to Amigal, treatment resulted in increased levels of the target enzyme (a-Gal A), as measured in ...

Video: Partnership Unites UCB with Consumer Product Innovator OXO(R)

... frequently than with placebo (n=614) were upper respiratory infection (20% CIMZIA, 13% placebo), urinary tract infection (7% CIMZIA, 6% placebo), and arthralgia (6% CIMZIA, 4% placebo). The proportion of patients who discontinued treatment due to adverse reactions in the controlled clinical studies was 8% for ...

Ferring Pharmaceuticals Unveils Six-Month Efficacy Data for EUFLEXXA(R) for the Treatment of Osteoarthritis Knee Pain

... to hyaluronate preparations or who have knee joint infections or skin diseases in the area of the injection site. Common adverse events reported were arthralgia (joint pain) and back pain. Temporary knee pain and swelling may occur after injection. Strict aseptic technique must be followed to avoid joint ...
Arthralgia in Medical Dictionary

Arthralgia

... arthralgia S - Joint pain s [ Med Help International ] [ ... possible by a generous donation from: ... arthralgia ( pain in one or more joints ) previous ... in the electrocardiogram ( EKG ) pattern ... arthralgia Joint pain . ElectrocardiogramMapping the ...

Joint

... tes for joint replacement and how the operation is performed. arthralgia S - Joint pain s [ Med Help International ] [ Search ] [ Ask the Doctor ... on Cancer for describing the extent of cancer in a patient’s body. arthralgia : Pain in a joint , not inflammatory in character. ASPARTATE ...

Arrhythmia

... narrows or fails to close properly. Various disease s can rob the heart of its muscle . ARRHYTHMIA : A change in the heart beat's rhythm. arthralgia : Pain in a joint , not inflammatory in character. Arrhythmia Mapping System Hardware and software system indicated as a diagnostic aid in ...

Brucellosis

... Acute brucellosis may begin with mild flu -like symptoms or with fever , chills , sweating , muscle aches ( myalgia ), joint aches ( arthralgia ), and malaise . Classically, fever spikes occur every afternoon to levels around 104 degrees Farenheit. Brucellosis is a disease caused by ...

Joint pain

... or curvature of the spine muscle weakness due to bones pressing on nerve s bone fractures resulting from minor injury arthritis ... arthralgia S - Joint pain s [ Med Help International ] [ Search ] [ Ask the Doctor Forums ] The medical glossary has been made possible by a generous donation ...

Muscle cramps

... extremities. Symptoms include leg swelling , leg pain , and muscle cramps . Women on exemestane had significantly more visual disturbances, arthralgia , diarrhea , and osteoporosis , but women on tamoxifen had significantly more gynecologic symptoms, muscle cramps , vagina l bleeding , ...

Myalgia

... much less common, can cause significant neck stiffness. Home Care: ... Women on letrozole had significantly more hot flashes, arthritis , arthralgia and myalgia , but less vagina l bleeding . " Bursitis , Tendinitis , Myofascial Pain , and Fibro myalgia ." In Conn's Current Therapy., ....

Mycosis

... infection causes symptoms in about 50% of cases. It usually presents as a flu -like illness with fever , chills , productive cough , myalgia , arthralgia and pleuritic chest pain . Onycho mycosis is difficult to treat because nails grow slowly and receive very little blood supply. However, ...

Neutropenia

... Serum Sickness Sickle Cell Trait ( Sickle Cell Anemia ) Sickle Cell Anemia ... stain; periodical; periodical index; periodicals; periodic arthralgia ; periodic biopolymer; periodic catatonia; periodic disease ; periodic fever ; periodic filariasis; periodicity; periodic law; periodic migrainous ...

Pain

... s in the upper thigh Apparent shortening of the leg, or legs of unequal length Hip stiffness that restricts movement in the hip ... arthralgia : Pain in a joint , not inflammatory in character. ASPARTATE AMINOTRANSAMINASE ( AST ): A liver enzyme that plays a role in protein ...

More>>

Arthralgia in Biological Technology

Cimzia(R) (certolizumab pegol) Provides Long-Term Remission and Response Rates in Infliximab-Refractory Crohn's Patients

... frequently than with placebo (n=614) were upper respiratory infection (20% CIMZIA, 13% placebo), urinary tract infection (7% CIMZIA, 6% placebo), and arthralgia (6% CIMZIA, 4% placebo). The proportion of patients who discontinued treatment due to adverse reactions in the controlled clinical studies was 8% for ...

Amicus Therapeutics Presents Positive Results From Phase 2 Extension Study of Amigal(TM) for Fabry Disease at ACMG 2009 Annual Meeting

... Treatment with Amigal was generally well-tolerated, with no drug-related serious adverse events. The most common adverse events were headache, arthralgia and diarrhea. Subjects identified as responders to Amigal at the completion of the Phase 2 studies continued to maintain elevated levels of ...

New Data Suggest CIMZIA(R) (Certolizumab Pegol) Active in Treating Moderate to Severe Crohn's Patients With Fistulizing Disease

... placebo (n=614) were upper respiratory infection (20% CIMZIA (R) , 13% placebo), urinary tract infection (7% CIMZIA (R) , 6% placebo), and arthralgia (6% CIMZIA (R) , 4% placebo). The proportion of patients who discontinued treatment due to adverse reactions in the controlled clinical studies ...

Gleevec Receives FDA Priority Review as First Therapy to Reduce Recurrence of Gastrointestinal Stromal Tumors After Surgery

... adverse reactions (all Grades) in the seven MDS/MPD patients assessed were nausea (57%); diarrhea and muscle cramps (43% each); anemia, fatigue, arthralgia and periorbital edema (29% each). All ASM patients experienced at least one adverse reaction at some time. The most frequently reported adverse ...

Kuvan, Naglazyme and Aldurazyme Data to Be Presented at the 57th Annual Meeting of the American Society of Human Genetics

... Adverse events reported by the greatest number of patients during the extension study included headache, cough, pyrexia, diarrhea, arthralgia and extremity pain. None of the adverse events that occurred during infusion were severe. The following relevant posters will also be ...
Arthralgia in Biological Definition

Ebola

... to four weeks. Symptoms are variable too, but the onset is usually sudden and characterised by high fever , prostration, myalgia (muscle pains), arthralgia (pain in the joints), abdominal pains and headache . These symptoms progress to vomiting , diarrhea , oropharyngeal lesions , conjunctivitis , ...

Malaria

... Louis Alphonse Laveran was awarded the Nobel Prize for Physiology or Medicine in 1907 . Symptoms of malaria include fever , shivering , arthralgia (joint pain), vomiting , and convulsions . There may be the feeling of tingling in the skin, particularly with malaria caused by P. falciparum . ...
Other Contents
(Date:5/29/2015)... May 29, 2015 This is ... state of the Naproxen industry.The report provides a ... applications and industry chain structure. The Naproxen ... markets including development trends, competitive landscape analysis, and ... discussed as well as manufacturing processes and cost ...
(Date:5/29/2015)... 2015 The FSH Society ... science of the little-known and incurable disease, facioscapulohumeral ... the second FSHD Trial Preparedness Workshop. The Workshop, ... University of Rochester Medical Center in Rochester, New ... around the world, including representatives from industry, the ...
(Date:5/29/2015)... (PRWEB) May 29, 2015 ... H1 2015” provides comprehensive information on the ... strengthens R&D pipelines by identifying new targets ... products. Complete report on H1 2015 pipeline ... data tables and 13 figures, spread across ...
(Date:5/29/2015)... For the third year, Nike Ultimate Camps will ... ultimate community an opportunity to experience ultimate training techniques in ... of the USAU Nike Ultimate Camp is to provide a ... character, and make lifelong friends. , The USAU Nike Ultimate ... skill and ability levels, ages 10-18. Camp will run from ...
(Date:5/29/2015)... 2015 A multi-center study led ... a urine test can determine if a patient ... Dr. James McKiernan presented these findings at the ... , Dr. McKiernan is the urologist-in-chief at ... chair of the Department of Urology at Columbia ...
Breaking Medicine News(10 mins):Health News:Naproxen Market Analysis For Global & China Regions 2020 Research Forecasts 2Health News:International Conference Brings Together Key Stakeholders to Advance Clinical Trial Readiness for FSHD 2Health News:International Conference Brings Together Key Stakeholders to Advance Clinical Trial Readiness for FSHD 3Health News:Axillary Hyperhidrosis Therapeutic Assessment Pipeline Review H1 2015 Market Research Report Available at RnRMarketResearch.com 2Health News:Axillary Hyperhidrosis Therapeutic Assessment Pipeline Review H1 2015 Market Research Report Available at RnRMarketResearch.com 3Health News:US Sports Camps, Nike Sports Camps, and USA Ultimate Host Third Summer of Ultimate Camp in Denver 2Health News:Urine Test Detects Prostate Cancer with 92 Percent Accuracy, According to Study 2Health News:Urine Test Detects Prostate Cancer with 92 Percent Accuracy, According to Study 3
(Date:5/22/2015)... -- According to a new market research ... Emotion, Forensic), by Software (Middleware, Databases), by Hardware (Cameras, Integrated ... Home) - Global Forecast to 2020", published by MarketsandMarkets, ... 2015 to $6.19 Billion by 2020, at a CAGR ... Tables and   43 Figures spread through 140 Pages ...
(Date:5/19/2015)... Fingerprint Cards (FPC) has received an ... and FPC1035 from one if its module partners. Deliveries are ... 2015 and the sensors will be used by smartphone manufacturers ... 2015 hereby amount to 740 MSEK to date. In addition ... and a number of smaller orders not separately communicated amounting ...
(Date:5/14/2015)... 2015  Verificient Technologies, Inc., a technology ... remote proctoring, announced a new alliance partnership ... creator of the Canvas Learning Management System ... will benefit from the seamless integration of ... a fully integrated multifactor biometrics behavioral application, ...
Breaking Biology News(10 mins):Facial Recognition Market Worth $6.19 Billion by 2020 2Facial Recognition Market Worth $6.19 Billion by 2020 3Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 230 Million and Raises Revenue Guidance for 2015 2Verificient and Instructure Announce Alliance Partnership to Provide Online Proctoring for K-12 and Higher Education Institutions 2
Other TagsOther Tags